Risk-sharing in the Pharmaceutical Industry

Risk-sharing in the Pharmaceutical Industry
Author :
Publisher : Springer Science & Business Media
Total Pages : 306
Release :
ISBN-10 : 9783790816686
ISBN-13 : 379081668X
Rating : 4/5 (86 Downloads)

Book Synopsis Risk-sharing in the Pharmaceutical Industry by : Gerrit Reepmeyer

Download or read book Risk-sharing in the Pharmaceutical Industry written by Gerrit Reepmeyer and published by Springer Science & Business Media. This book was released on 2006-02-25 with total page 306 pages. Available in PDF, EPUB and Kindle. Book excerpt: The productivity in pharmaceutical research and development faces intense pres sure. R&D expenditures of the major US and European companies have topped US$ 33 billion in 2003 compared to around US$ 13 billion just a decade ago. At the same time, the number of new drug approvals has dropped from 53 in 1996 to only 35 in 2003. Moreover, the protraction of clinical trials has significantly reduced the effective time of patent protection. The consequences are devastating. Monopoly profits have started to decline and the average costs per new drug have reached a re cord level of close to US$ 1 billion today. As a result, any failure of a new sub stance in the R&D process can lead to considerable losses, and the risks of introduc ing a new drug to the market have grown tremendously. Particularly if a company is highly dependent on just a handful of mega-selling blockbuster drugs, the risks can be even greater. For example, Pfizer generated about 90% of its worldwide revenues in 2002 with just 8 products. Any shortfall of a promising late-stage drug candidate would have left Pfizer with a gaping hole in its product portfolio. In order to deal with these risks, many pharmaceutical companies have started to organize their R&D in partnership. In fact, more than 600 alliances in pharmaceutical R&D are signed every year.


Risk-sharing in the Pharmaceutical Industry Related Books

Risk-sharing in the Pharmaceutical Industry
Language: en
Pages: 306
Authors: Gerrit Reepmeyer
Categories: Business & Economics
Type: BOOK - Published: 2006-02-25 - Publisher: Springer Science & Business Media

DOWNLOAD EBOOK

The productivity in pharmaceutical research and development faces intense pres sure. R&D expenditures of the major US and European companies have topped US$ 33
Sharing Clinical Trial Data
Language: en
Pages: 236
Authors: Institute of Medicine
Categories: Medical
Type: BOOK - Published: 2015-04-20 - Publisher: National Academies Press

DOWNLOAD EBOOK

Data sharing can accelerate new discoveries by avoiding duplicative trials, stimulating new ideas for research, and enabling the maximal scientific knowledge an
Pharmaceutical R&D
Language: en
Pages: 380
Authors:
Categories: Medical
Type: BOOK - Published: 1993 - Publisher: DIANE Publishing

DOWNLOAD EBOOK

Analyzes the costs, risks, and economic rewards of pharmaceutical R&D and the impact of public policy on both costs and returns. Examines the rapid increase in
Risk Management Applications in Pharmaceutical and Biopharmaceutical Manufacturing
Language: en
Pages: 432
Authors: Hamid Mollah
Categories: Science
Type: BOOK - Published: 2013-03-18 - Publisher: John Wiley & Sons

DOWNLOAD EBOOK

Sets forth tested and proven risk management practices in drug manufacturing Risk management is essential for safe and efficient pharmaceutical and biopharmaceu
Making Medicines Affordable
Language: en
Pages: 235
Authors: National Academies of Sciences, Engineering, and Medicine
Categories: Medical
Type: BOOK - Published: 2018-03-01 - Publisher: National Academies Press

DOWNLOAD EBOOK

Thanks to remarkable advances in modern health care attributable to science, engineering, and medicine, it is now possible to cure or manage illnesses that were